ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions
View by Date

Saturday, November 7, 2020

9:00AM-11:00AM
Abstract Number: 0646
“An Apple Pie a Day Does Not Keep the Doctor Away”. Fictional Depictions of Gout in Contemporary Film and Television
Metabolic & Crystal Arthropathies Poster
9:00AM-11:00AM
Abstract Number: 0814
“I Want to Switch Back”: Real-world Experience of Switching Intravenous Abatacept and Tocilizumab to Subcutaneous Injection During the COVID-19 Pandemic
RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World
9:00AM-11:00AM
Abstract Number: 0737
“It’ll Go Away. There’s Nothing Wrong with you:” the Experience of Pain-Related Stigma Among Adolescents with Pain Amplification Syndrome
Pediatric Rheumatology – Clinical Poster II: JIA
9:00AM-11:00AM
Abstract Number: 0630
“No Benefit from a Strict Immobilization in Vertebral Osteomyelitis” Vertebral Immobilization and Neurological Complication in Acute Pyogenic Vertebral Osteomyelitis: SPONDIMMO, a Prospective Cohort of 250 Patients
Infection-related Rheumatic Disease Poster
9:00AM-11:00AM
Abstract Number: 0786
A Combination of Dimensionality Reduction Techniques Reveals Novel HLA-DR+ ‘Candidate’ Antigen-Presenting Cell Subsets (cAPC) in Patients with Rheumatoid Arthritis (RA)
RA – Etiology & Pathogenesis Poster
9:00AM-11:00AM
Abstract Number: 0725
A Data Science Evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Questionnaire for Improving Management of JIA Patients
Pediatric Rheumatology – Clinical Poster II: JIA
9:00AM-11:00AM
Abstract Number: 0874
A Multi-Center, Randomized, Double-blind, Placebo-controlled Dose-ranging Study Evaluating Efficacy and Safety of SHR-1314 in Subjects with Moderate-to-Severe Plaque Psoriasis
Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster II
9:00AM-11:00AM
Abstract Number: 0677
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR): 12-Month Results of an Open-Label Study
Metabolic & Crystal Arthropathies Poster
9:00AM-11:00AM
Abstract Number: 0649
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients with Uncontrolled Gout Who Have Undergone Kidney Transplantation: Early Data Report
Metabolic & Crystal Arthropathies Poster
9:00AM-11:00AM
Abstract Number: 0581
A Proposed Economic Framework to Model the Consequences of Psoriatic Arthritis Disease Domains
Health Services Research Poster
9:00AM-11:00AM
Abstract Number: 0529
A Prospective Study on the Incidence of a First Thrombo-embolic Event in Patients with Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies
Antiphospholipid Syndrome Poster
9:00AM-11:00AM
Abstract Number: 0798
A Randomized, Double-blind Phase 3 Study Comparing the Efficacy, Safety and Immunogenicity of PF-06410293 (Abrilada™), an Adalimumab (ADL) Biosimilar, and Reference ADL (Humira®) in Patients with Moderate to Severe Active RA: Results from Weeks 52-92
RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World
9:00AM-11:00AM
Abstract Number: 0800
A Randomized, Double-Blind, Phase 3 Study to Compare the Efficacy and Safety of a Proposed High Concentration (100 mg/mL) Adalimumab Biosimilar (CT-P17) with Reference Adalimumab in Patients with Moderate-to-Severe Active Rheumatoid Arthritis
RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World
9:00AM-11:00AM
Abstract Number: 0592
A Rheumatology-Driven Protocol and Treatment Algorithm of SARS-CoV-2 Cytokine Release Syndrome and Its Associated Outcomes
Health Services Research Poster
9:00AM-11:00AM
Abstract Number: 0656
A Sugar Tax Results in Reduced Incident Gout, Quality Adjusted Life Years Lost and Economic Cost from Gout: A Health Economic Analysis
Metabolic & Crystal Arthropathies Poster
  • 1
  • 2
  • 3
  • …
  • 32
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.